Antimicrobials Flashcards
Define MIC (Minimal Inhibitory Concentration):
the lowest antimicrobial concentration that prevents visible bacterial growth after overnight incubation. A standard inoculum is introduced to serial dilutions of antibiotics.
Define MBC (minimum bactericidal concentration)
the lowest concentration of antimicrobial that will prevent the growth of an organism after subculture on to antibiotic free media. Clear tubes from MIC are subcultured.
Vancomycin spectrum and MOA
Spectrum: Gram (+) bacteria incl. MRSA and C. difficile (PO)
Mechanism: inhibit cell wall synthesis by binding to terminal D-Ala-D-Ala of peptidoglycan precursors
Vancomycin resistance mechanisms
Resistance mechanisms:
1) Altered target site (terminal D-Ala-D-Ala)
S. aureus (vanA gene, VRSA), E. faecium (vanA gene), E. faecalis (vanB gene)
2) Cell wall thickening
Vancomycin intermediate S. aureus (VISA)
Fosfomycin
Spectrum: Gram (+) and Gram (-) bacteria
Mechanism: inhibits peptidoglycan synthesis (formation of N-acetylmuramic acid)
Which classes of drugs are considered beta-lactams
penicillins, cephalosporins, carbapenems, monobactams (aztreonam)
Beta-lactams spectrum and MOA
Spectrum: Gram (+) and Gram (-) bacteria; monobactams only cover Gram (-) bacteria
Mechanism: inhibit cell wall synthesis by preventing the final cross-linking of the cell wall by PBPs
What are the resistance mechanisms to beta-lactams
1) Altered penicillin binding proteins
Gram (+) bacteria incl. MRSA (mecA), S. pneumoniae, and E. faecium
2) B-lactamase enzymes
Gram (-) bacteria, S. aureus, B. cereus
3) Efflux pumps (actively pump the drug out)
Gram (-) bacteria
4) Porin mutations (prevent the drug from entering)
Gram (-) bacteria
Define narrow spectrum beta-lactamase
resistance to penicillins and narrow spectrum cephalosporins
Define ESBL
resistance to penicillins, narrow and extended spectrum cephalosporins and monobactams, but not cephamycins or carbapenems
Define KPC
Klebsiella pneumoniae carbapenemases (KPC): resistance to penicillins, narrow and extended spectrum cephalosporins, and carbapenems
Define ampC
resistance to penicillins, cephalosporins (excluding 4th generation) and cephamycins; inhibited by boronic acid and cloxacillin
Which organisms have inducible ampC
Enterobacter, Serratia, Citrobacter, Providencia, Morganella, Pseudomonas, Aeromonas (ESCPM+); E. coli does not have inducible AmpC, but mutations can cause increased expression, leading to resistance
Name the beta-lactamase inhibitors
Clavulanate
Sulbactam
Tazobactam
Beta-lactamase inhibitors spectrum and mechanism
Spectrum: when used in combination with B-lactams, inhibits bacteria with narrow spectrum B-lactamases and ESBLs; clavulanate and tazobactam may inhibit bacteria with KPCs
Mechanism: structural analogues to B-lactams that irreversibly bind to B-lactamase enzymes, inhibiting their activity
name the aminoglycosides
Gentamicin
Tobramycin
Amikacin
Streptomycin
aminoglycosides spectrum and MOA
Spectrum: Gram (+) and Gram (-) bacteria; need aerobic energy to enter the cell
Mechanism: inhibit protein synthesis by binding to 16S rRNA within the 30S ribosomal subunit
Aminoglycoside resistance mechanisms
1) Decreased cell wall permeability Intrinsic in most Gram (-) bacilli 2) Efflux pumps 3) Target site alteration Erm gene: methylates ribosome and prevents drug binding; inducible clindamycin resistance with erythromycin (S. aureus)
Tetracycline spectrum and MOA
Spectrum: Gram (+) and Gram (-) bacteria incl. Chlamydia, Mycoplasma, Rickettsia
Mechanism: inhibit protein synthesis by binding to 30S ribosomal subunit
Tetracyclines resistance mechanisms
1) Efflux pumps
2) Target site alteration
3) Enzymatic inactivation
Bacteroides spp.
Tigecycline spectrum and MOA
Spectrum: Gram (+) and Gram (-) bacteria, anaerobes
Mechanism: ribosome inhibition
Linezolid spectrum and MOA
Spectrum: Gram (+) bacteria including MRSA and VRE
Mechanism: ribosome inhibition
Quinolones (–floxacin) spectrum and MOA
Spectrum: Strep, Gram (-) bacteria, atypical bacteria, anaerobes (moxifloxacin), M. tuberculosis (moxifloxacin)
Mechanism: inhibits DNA replication by binding topoisomerase IV and DNA gyrase
Quinolones resistance mechanisms
1) Target site mutations
Pseudomonas: topoisomerase mutations
2) Reduced permeability of outer membrane proteins